Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025)

Corcept Therapeutics (CORT) has disclosed Change in Taxes for 5 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Change in Taxes fell 15.6% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 71.09% year-over-year, with the annual reading at $1.1 million for FY2025, 71.09% down from the prior year.
  • Change in Taxes hit $1.0 million in Q4 2025 for Corcept Therapeutics, up from -$1.5 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $2.5 million in Q2 2022 to a low of -$1.5 million in Q3 2025.
  • Historically, Change in Taxes has averaged $738900.0 across 5 years, with a median of $579500.0 in 2021.
  • Biggest five-year swings in Change in Taxes: skyrocketed 56950.0% in 2022 and later plummeted 269.78% in 2025.
  • Year by year, Change in Taxes stood at -$4000.0 in 2021, then surged by 56950.0% to $2.3 million in 2022, then plummeted by 107.17% to -$163000.0 in 2023, then skyrocketed by 858.9% to $1.2 million in 2024, then decreased by 15.6% to $1.0 million in 2025.
  • Business Quant data shows Change in Taxes for CORT at $1.0 million in Q4 2025, -$1.5 million in Q3 2025, and $1.4 million in Q2 2025.